ConductScience.org, home

Paper33782898

Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction.

Alam T and 3 others. Drug Deliv Transl Res, 2022. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. Papers, record 33782898. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33782898

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction.
PubMed
Journal
Drug Deliv Transl Res
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2026-10-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alam TTausif
2Ansari MAMohd Asif
3Baboota SSanjula
4Ali JJavedhttps://orcid.org/0000-0001-5308-0655

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
Myocardial InfarctionMajor topic
NanostructuresMajor topic
Administration, Oral
Animals
Antioxidants
Drug Carriers
Isoproterenol
Isradipine
Lipids
Particle Size
Rats

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17945331In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.Biochem Biophys Res Commun1994https://conductscience.org/library/papers/7945331PubMed
229235598The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers.Nanoscale2018https://conductscience.org/library/papers/29235598PubMed
316321796Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.Philos Trans R Soc Lond B Biol Sci2005https://conductscience.org/library/papers/16321796PubMed
424641324Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation.Drug Dev Ind Pharm2015https://conductscience.org/library/papers/24641324PubMed
528284054Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability.Colloids Surf B Biointerfaces2017https://conductscience.org/library/papers/28284054PubMed
616521536[Electron microscopy description of cardiomyocytes from the left ventricle of rat heart after apoptosis induction by isoproterenol].Izv Akad Nauk Ser Biol2006https://conductscience.org/library/papers/16521536PubMed
717330072Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.Nat Rev Drug Discov2007https://conductscience.org/library/papers/17330072PubMed
823535345Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.Int J Pharm2013https://conductscience.org/library/papers/23535345PubMed
925138256Amorphous isradipine nanosuspension by the sonoprecipitation method.Int J Pharm2014https://conductscience.org/library/papers/25138256PubMed
1030935913QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.Int J Pharm2019https://conductscience.org/library/papers/30935913PubMed
1121515375The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.Neurobiol Dis2011https://conductscience.org/library/papers/21515375PubMed
1221640809Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.Int J Pharm2011https://conductscience.org/library/papers/21640809PubMed
1329402457Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers.Int J Biol Macromol2018https://conductscience.org/library/papers/29402457PubMed
1430076853Adaptation of Quality by Design-Based Development of Isradipine Nanostructured-Lipid Carrier and Its Evaluation for In Vitro Gut Permeation and In Vivo Solubilization Fate.J Pharm Sci2018https://conductscience.org/library/papers/30076853PubMed
1536810Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.Anal Biochem1979https://conductscience.org/library/papers/36810PubMed
1619406231Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.Eur J Pharm Sci2009https://conductscience.org/library/papers/19406231PubMed
1724364934Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.Mater Sci Eng C Mater Biol Appl2012https://conductscience.org/library/papers/24364934PubMed
1830551388Effects of nimodipine, vinpocetine and their combination on isoproterenol-induced myocardial infarction in rats.Biomed Pharmacother2019https://conductscience.org/library/papers/30551388PubMed
191827026The place of isradipine in the treatment of hypertension.Am J Hypertens1991https://conductscience.org/library/papers/1827026PubMed
2026829018Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study.Artif Cells Nanomed Biotechnol2017https://conductscience.org/library/papers/26829018PubMed

See all 25 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42579251Application of nanotherapy in cardiovascular diseases featuring novel pharmacological mechanisms and drug delivery strategies.Discov Nano2026https://conductscience.org/library/papers/42579251PubMed
41839827Nanoparticles-based phototherapy systems: molecular mechanisms and clinical applications.Signal Transduct Target Ther2026https://conductscience.org/library/papers/41839827PubMed
40978960Enhancing Drug Efficacy: A Review of Research Progress in Drug-Loaded Microspheres.Cureus2025https://conductscience.org/library/papers/40978960PubMed
36768536Neurogenic Hypertension, the Blood-Brain Barrier, and the Potential Role of Targeted Nanotherapeutics.Int J Mol Sci2023https://conductscience.org/library/papers/36768536PubMed
36507276mRNA therapy for myocardial infarction: A review of targets and delivery vehicles.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36507276PubMed
34845679In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours.Drug Deliv Transl Res2023https://conductscience.org/library/papers/34845679PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33782898

GET https://conductscience.org/api/papers/v1/33782898/references?page=2